Feasibility of autologous plasma gel for tonsil-derived stem cell therapeutics in hypoparathyroidism

Volume: 8, Issue: 1
Published: Aug 9, 2018
Abstract
Hypoparathyroidism is a deficiency of the parathyroid hormone (PTH) in the body. We previously reported the possibility of treating it using tonsil-derived mesenchymal stem cells (TMSCs) differentiated into PTH-releasing cells. The purpose of this study was to evaluate the feasibility of using autologous plasma gel as scaffold material in treatment of hypoparathyroidism with TMSC. We obtained plasma by venous sampling of autologous blood and...
Paper Details
Title
Feasibility of autologous plasma gel for tonsil-derived stem cell therapeutics in hypoparathyroidism
Published Date
Aug 9, 2018
Volume
8
Issue
1
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.